Table 2 Baseline demographics and clinical characteristics of the patient population
Parameters | Baseline demographics and clinical characteristics |
|---|---|
No. of subjects | 101 |
Sex (M/F) | 63/38 (62.4%/37.6%) |
Age (mean) (year) | 57.06 ± 9.72 |
RISS stage | |
 Stage I | 11 (10.9%) |
 Stage II | 52 (51.5%) |
 Stage III | 38 (37.6%) |
Type | |
 IgA λ | 11 (10.9%) |
 IgD λ | 8 (7.9%) |
 IgG λ | 31 (30.7%) |
 λ | 19 (18.8%) |
 IgA κ | 11 (10.9%) |
 IgG κ | 15 (14.9%) |
 κ | 6 (5.9%) |
Therapeutic response | |
 CR | 35 (34.7%) |
 sCR | 22 (21.8%) |
 PR | 20 (19.8%) |
 VGPR | 15 (14.9%) |
 SD | 6 (5.9%) |
 PD | 3 (3%) |